CHARLOTTE KNIGHT: Open Payments
NPI 1427521053 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,914 in 110 payments from 18 companies in 2025. Trend: 2023 $955 · 2024 $2,129 · 2025 $1,914
Food & beverage: $1,914
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $227 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $154 |
| GENZYME CORPORATION | 6 | $152 |
| Janssen Biotech, Inc. | 6 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| Aimmune Therapeutics, Inc. | 6 | $113 |
| Ardelyx, Inc. | 5 | $102 |
| Gilead Sciences, Inc. | 5 | $86 |
| Madrigal Pharmaceuticals | 3 | $85 |
Products named: DUPIXENT, ENTYVIO, XIFAXAN, RINVOQ, TREMFYA, IBSRELA, SKYRIZI, REZDIFFRA.
Industry payments across TN — which companies pay providers there.
